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Metalloproteases play a complex role in tumor progression. Proteomic approaches 
to identify the array of substrates of a given metalloprotease (degradome), can help to 
unveil its role in tumor growth and metastasis. Here we describe a proteomic screening 
to compare the proteins secreted by MCF7 cells, derived from an invasive mammary 
tumor, and the same cells expressing shRNAs that knock down ADAM10 or -17. Cells 
grown in conditions were the protease is expressed or knocked down were differentially 
labeled, by incorporating isotopically labeled amino acids (SILAC). Glycoproteins 
from the conditioned media of each of the two cell cultures were purified by affinity 
chromatography. The samples were then pooled and run on a 1D SDS-PAGE gel. The gel 
lane was then cut into 20 fractions and digested. Each fraction was analyzed by RP-LC-
MS/MS. Protein identification and quantification of relative abundances was performed 
using WARP-LC, an integrated software platform for LC-MS/MS workflows.
A number of known substrates of both proteases were identified as such in the 
analysis, showing the expected decrease of the shed extracellular domain abundance 
in the medium upon knock down of the protease. Thus, the cell-adhesion proteins 
E-cadherin and Desmoglein-2, or the PTP receptor-type k, were identified as substrates 
of ADAM10. Fractalkine and NCAML1 were found as substrates of ADAM17.
In addition several new candidate substrates of both proteases were identified. 
Among them, the GPI-anchored protein C4.4A, was identified and further validated 
as substrate of both ADAM10 and ADAM17 proteases. According to the identified 
peptides, both proteases cleave this protein close to the juxtamembrane region, 
releasing a soluble form devoid of the GPI-anchor. C4.4A protein, homologous to the 
urokinase-type plasminogen activator receptor, has been related to tumor invasion and 
metastasis. Cleavage of this protein by ADAMs constitutes a previously unknown level 
of regulation of its function.
